Axsome Therapeutics, Inc.AXSMNASDAQ
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | 39.53% |
| Q3 2025 | 1.55% |
| Q2 2025 | 19.26% |
| Q1 2025 | 20.69% |
| Q4 2024 | -15.96% |
| Q3 2024 | 18.58% |
| Q2 2024 | -16.07% |
| Q1 2024 | 30.71% |
| Q4 2023 | -58.61% |
| Q3 2023 | 7.40% |
| Q2 2023 | -498.77% |
| Q1 2023 | 81.68% |
| Q4 2022 | -36.63% |
| Q3 2022 | -8.17% |
| Q2 2022 | -4.56% |
| Q1 2022 | -16.65% |
| Q4 2021 | 2.60% |
| Q3 2021 | -8.05% |
| Q2 2021 | -10.34% |
| Q1 2021 | -0.33% |
| Q4 2020 | -27.22% |
| Q3 2020 | -25.09% |
| Q2 2020 | 43.58% |
| Q1 2020 | -30.95% |
| Q4 2019 | -29.64% |
| Q3 2019 | -39.04% |
| Q2 2019 | -29.34% |
| Q1 2019 | -10.87% |
| Q4 2018 | -15.88% |
| Q3 2018 | -0.01% |
| Q2 2018 | -72.32% |
| Q1 2018 | 35.33% |
| Q4 2017 | -15.50% |
| Q3 2017 | 9.19% |
| Q2 2017 | 11.39% |
| Q1 2017 | -9.09% |
| Q4 2016 | -1.87% |
| Q3 2016 | -5.61% |
| Q2 2016 | -16.13% |
| Q1 2016 | -242.25% |